Literature DB >> 2848330

Lung angiotensin converting enzyme activity in rats with differing susceptibilities to chronic hypoxia.

P Jederlinic1, N S Hill, L C Ou, B L Fanburg.   

Abstract

The decrease in lung angiotensin converting enzyme (ACE) activity occurring in rats during chronic hypoxia might be related to the pulmonary haemodynamic response or to the hypoxia. A study in rats was carried out to investigate this question. Rats from the Hilltop (H) strain are known to develop more severe pulmonary hypertension as a result of chronic hypoxia than rats from the Madison (M) strain despite having virtually identical arterial and mixed venous oxygen tensions. Rats from H and M strains were exposed to hypoxia (0.5 atm) for 3-21 days and lung and serum ACE activities were determined. After three days' hypobaria lung ACE activity was significantly lower and serum ACE significantly higher in H than in M rats. Linear regressions for lung ACE activity and right ventricular:body weight ratios showed significant inverse correlations and were similar in the two strains. The results suggest that pulmonary hypertension and not hypoxia determines the reduction in lung ACE activity, possibly by releasing ACE into the blood stream.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848330      PMCID: PMC461459          DOI: 10.1136/thx.43.9.703

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.

Authors:  R M Zakheim; L Mattioli; A Molteni; K B Mullis; J Bartley
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

2.  Ventricular weight in cardiac hypertrophy.

Authors:  R M FULTON; E C HUTCHINSON; A M JONES
Journal:  Br Heart J       Date:  1952-07

Review 3.  Pulmonary endothelial cells.

Authors:  J W Ryan; U S Ryan
Journal:  Fed Proc       Date:  1977-12

4.  Membrane-bound angiotensin-converting enzyme from rat lung.

Authors:  J J Lanzillo; B L Fanburg
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

5.  The effect of chronic alveolar hypoxia on lung and serum angiotensin I converting enzyme activity.

Authors:  A Molteni; R M Zakheim; K B Mullis; L Mattioli
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

6.  Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia.

Authors:  R M Jackson; A J Narkates; S Oparil
Journal:  J Appl Physiol (1985)       Date:  1986-04

7.  Lung angiotensin converting enzyme activity in rats with pulmonary hypertension.

Authors:  P M Keane; J M Kay; K L Suyama; D Gauthier; K Andrew
Journal:  Thorax       Date:  1982-03       Impact factor: 9.139

8.  Ventilatory responses and blood gases in susceptible and resistant rats to high altitude.

Authors:  L C Ou; N S Hill; S M Tenney
Journal:  Respir Physiol       Date:  1984-11

9.  Lung angiotensin converting enzyme activity in chronically hypoxic rats.

Authors:  J M Kay; P M Keane; K L Suyama; D Gauthier
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

10.  Effect of chronic hypoxia on angiotensin-induced pulmonary vasoconstriction and converting enzyme activity in the rat.

Authors:  R W Caldwell; C M Blatteis
Journal:  Proc Soc Exp Biol Med       Date:  1983-03
View more
  3 in total

1.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.

Authors:  C M Hoorn; R A Roth
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.